GlassScriptPhysician profile
Suzanne Marie Staraitis
NPI 1346537735
$6,272.63
in general payments reported to CMS, 2019-2025
46 companies · $1,848 in 2025
The $1,848 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $169 · 2021: $564 · 2022: $767 · 2023: $1,229 · 2024: $1,293 · 2025: $1,848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,298 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,297.62 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,015.15 | 2019-2025 | |
| Abbvie INC. | $961.62 | 2019-2025 | Ubrelvy, Qulipta |
| Lilly USA, LLC | $419.72 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $398.20 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astellas Pharma US INC | $348.70 | 2019-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $303.38 | 2021-2025 | Spravato, Acclarent Se Inflation Device |
| Exact Sciences Corporation | $232.55 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $227.26 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.70 | 2022-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $203.09 | 2022 | |
| Merck Sharp & Dohme LLC | $177.10 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Glaxosmithkline, LLC. | $165.36 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Medtronic, INC. | $139.27 | 2021-2024 | Venaseal |
| Abbott Laboratories | $138.74 | 2024-2025 | Freestyle Libre 2 |
| Dexcom, INC. | $117.48 | 2022-2025 | Dexcom G6 Transmitter |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Staraitis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.